Cargando…

Commentary on “Role of phototherapy in the era of biologics”

Detalles Bibliográficos
Autor principal:	Botsali, Aysenur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2021
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267715/ https://www.ncbi.nlm.nih.gov/pubmed/32950544 http://dx.doi.org/10.1016/j.jaad.2020.08.128

Ejemplares similares

Response to: “Commentary on ‘Role of phototherapy in the era of biologics’”
por: Torres, Angeli Eloise, et al.
Publicado: (2021)

Successful implementation of phototherapy guidelines during the COVID-19 pandemic
por: Dragan, Emma, et al.
Publicado: (2021)

Response to: “Successful implementation of phototherapy guidelines during the COVID-19 pandemic”
por: Lim, Henry W., et al.
Publicado: (2021)

Commentary
por: Shin, Daniel B., et al.
Publicado: (2021)

#DermTwitter and digital mentorship in the COVID-19 era
por: Zheng, David X., et al.
Publicado: (2021)

Using cyclosporine in the COVID era: An emergent need for caution
por: Khurana, Ananta, et al.
Publicado: (2020)

Invited commentary on the letter “The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations”
por: Kovarik, Carrie, et al.
Publicado: (2020)

Conducting inpatient dermatology consultations and maintaining resident education in the COVID-19 telemedicine era
por: Hammond, Margaret I., et al.
Publicado: (2020)

The oral cavity cannot be forgotten in the COVID-19 era: Is there a connection between dermatologic and oral manifestations?
por: Bemquerer, Larissa Marques, et al.
Publicado: (2021)

Importance of nose wires in face masks: A reply to “Diagnostic and management considerations for “maskne” in the era of COVID-19”
por: Kassamali, Bina, et al.
Publicado: (2021)

Optimal time for the resumption of biologics after COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution
por: Kansal, Naveen Kumar
Publicado: (2020)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Novel solutions for dermatologic care of geriatric patients and the role of the dermatology house call
por: Lipner, Shari R., et al.
Publicado: (2020)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

A potential hidden reservoir: The role of nail hygiene in preventing transmission of COVID-19
por: Wu, Albert G., et al.
Publicado: (2020)

Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
por: Bukovac, Domen, et al.
Publicado: (2021)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021)

Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021)

COVID-19 compels closer scrutiny of disparities in dermatology
por: Temiz, Laurie A., et al.
Publicado: (2021)

Comment on “Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic”
por: Salman, Andac, et al.
Publicado: (2021)

A response to “Male balding is a major risk factor for severe COVID-19”
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
por: Yousaf, Ahmed, et al.
Publicado: (2021)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19
por: Xu, Qiannan, et al.
Publicado: (2021)

Strategies for effective medical student education in dermatology during the COVID-19 pandemic
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2021)

Simple solutions for the fogging of spectacles when wearing surgical masks
por: Bhardwaj, Abhishek, et al.
Publicado: (2021)

Drop dermoscopy for teledermatology
por: Kaliyadan, Feroze, et al.
Publicado: (2021)

Absence of specific cutaneous manifestations of severe acute respiratory syndrome coronavirus 2 in a reference center in Brazil
por: Avancini, Joao, et al.
Publicado: (2021)

Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021)

Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Schultz, Brittney, et al.
Publicado: (2021)

A disposable diaper in an N95 respirator
por: Song, Zexing, et al.
Publicado: (2021)

Trends in teledermatology use during clinic reopening after COVID-19 closures
por: Su, Mack Y., et al.
Publicado: (2021)

Reply to comment on: The Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2021)

The underrepresentation of “COVID toes” in skin of color: An example of racial bias or evidence of a tenuous disease association?
por: Cline, Abigail, et al.
Publicado: (2021)

Preliminary outcomes of 2020-2021 dermatology residency application cycle and adverse effects of COVID-19
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1pt1eef3d875j7ctpc424thrtg